Quality of Life of Survivors of Thyroid Cancer Is Not Inferior to That in Subjects without Cancer: Long-Term after Over 5 Years
暂无分享,去创建一个
Jung-Min Lee | S. Chang | Min-Hee Kim | Jeongmin Lee | D. Lim | Youn-Ju Lee | Jung‐Min Lee
[1] U. Megwalu,et al. Thyroid Cancer Incidence and Mortality Trends in the United States: 2000 - 2018. , 2022, Thyroid : official journal of the American Thyroid Association.
[2] T. Okamoto,et al. Fatigue and quality of life among thyroid cancer survivors without persistent or recurrent disease , 2022, Endocrine connections.
[3] M. Shong,et al. Effect of Thyroid-Stimulating Hormone Suppression on Muscle Function After Total Thyroidectomy in Patients With Thyroid Cancer , 2021, Frontiers in Endocrinology.
[4] D. Fuhrer,et al. 2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer , 2019, European Thyroid Journal.
[5] F. Pitoia,et al. Dynamic risk assessment in patients with differentiated thyroid cancer. , 2019, Endocrine-related cancer.
[6] S. Yount,et al. Clinical factors associated with worse quality-of-life scores in United States thyroid cancer survivors. , 2019, Surgery.
[7] S. Yount,et al. Post-thyroidectomy neck appearance and impact on quality of life in thyroid cancer survivors. , 2019, Surgery.
[8] E. Lee,et al. Prediction of Cancer Incidence and Mortality in Korea, 2019 , 2019, Cancer research and treatment : official journal of Korean Cancer Association.
[9] E. Cvejic,et al. Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical Treatment , 2019, JAMA otolaryngology-- head & neck surgery.
[10] K. Devon,et al. Differences in long-term quality of life between hemithyroidectomy and total thyroidectomy in patients treated for low-risk differentiated thyroid carcinoma. , 2019, Surgery.
[11] C. Bădulescu,et al. Psychological impact of 131I radioprotection measures on thyroid cancer patients , 2018, Clujul medical.
[12] C. Jimeno,et al. Validity and Reliability of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 – Tagalog among Adult Filipinos with Differentiated Thyroid Cancer* , 2018, Journal of the ASEAN Federation of Endocrine Societies.
[13] D. Yin,et al. The association between thyroid cancer and insulin resistance, metabolic syndrome and its components: A systematic review and meta-analysis. , 2018, International journal of surgery.
[14] Yan-jun Ren,et al. Health-Related Quality of Life of Community Thyroid Cancer Survivors in Hangzhou, China. , 2018, Thyroid : official journal of the American Thyroid Association.
[15] Ken R. Smith,et al. Risk Factors for Cardiovascular Disease Among Thyroid Cancer Survivors: Findings From the Utah Cancer Survivors Study , 2018, The Journal of clinical endocrinology and metabolism.
[16] N. Tolley,et al. Quality of life in differentiated thyroid cancer. , 2017, International journal of surgery.
[17] Ken R. Smith,et al. Aging-Related Disease Risks among Young Thyroid Cancer Survivors , 2017, Cancer Epidemiology, Biomarkers & Prevention.
[18] Kyu-Won Jung,et al. Prediction of Cancer Incidence and Mortality in Korea, 2017 , 2017, Cancer research and treatment : official journal of Korean Cancer Association.
[19] Kaliszewski,et al. American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .
[20] M. Jung,et al. Post-treatment cognitive dysfunction in women treated with thyroidectomy for papillary thyroid carcinoma , 2017, Supportive Care in Cancer.
[21] R. Peeters,et al. Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer , 2016, Clinical endocrinology.
[22] K. Yi. The Revised 2016 Korean Thyroid Association Guidelines for Thyroid Nodules and Cancers: Differences from the 2015 American Thyroid Association Guidelines , 2016, Endocrinology and metabolism.
[23] A. Jemal,et al. Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[24] G. Fattore,et al. A comparison of EuroQol 5-Dimension health-related utilities using Italian, UK, and US preference weights in a patient sample , 2016, ClinicoEconomics and outcomes research : CEOR.
[25] P. Perros,et al. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines , 2016, The Journal of Laryngology & Otology.
[26] Nan Luo,et al. The EQ-5D-5L valuation study in Korea , 2016, Quality of Life Research.
[27] M. Schlumberger,et al. Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Joanna Waligórska-Stachura,et al. ThyPROpl--The Polish version of the thyroid-specific quality of life questionnaire ThyPRO. , 2015, Endokrynologia Polska.
[29] H. Y. Kim,et al. A prospective comparison of patient body image after robotic thyroidectomy and conventional open thyroidectomy in patients with papillary thyroid carcinoma. , 2014, Surgery.
[30] T. Kwon,et al. Comparison of health-related quality of life between cancer survivors treated in designated cancer centers and the general public in Korea. , 2014, Japanese journal of clinical oncology.
[31] Jian-kui Han,et al. Thyroid tumor-initiating cells: Increasing evidence and opportunities for anticancer therapy (Review) , 2014, Oncology reports.
[32] M. B. Gillespie,et al. Salivary Morbidity and Quality of Life following Radioactive Iodine for Well-Differentiated Thyroid Cancer , 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[33] R. Kloos,et al. In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 μU/mL after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulin. , 2013, Thyroid : official journal of the American Thyroid Association.
[34] L. V. van de Poll-Franse,et al. Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors , 2013, Acta oncologica.
[35] A. Hinz,et al. Quality of life in patients with thyroid cancer compared with the general population. , 2012, Thyroid : official journal of the American Thyroid Association.
[36] G. Pentheroudakis,et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[37] Andrew Lloyd,et al. Health Utilities Using the EQ-5D in Studies of Cancer , 2012, PharmacoEconomics.
[38] Soo Hyun Kim,et al. Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea , 2010, Health and quality of life outcomes.
[39] Paul Kind,et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[40] C. Benbassat,et al. Illness perception in patients with differentiated epithelial cell thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[41] L. Krook,et al. Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma. , 2008, Thyroid : official journal of the American Thyroid Association.
[42] J. Romijn,et al. Quality of life in cured patients with differentiated thyroid carcinoma. , 2008, The Journal of clinical endocrinology and metabolism.
[43] J. Thumboo,et al. Health‐Related Quality of Life in Thyroid Cancer Survivors , 2007, The Laryngoscope.
[44] B. Weintraub,et al. A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. , 2006, The Journal of clinical endocrinology and metabolism.
[45] Jeroen J. Bax,et al. Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial , 2006, Clinical endocrinology.
[46] A. Bockisch,et al. Health-related Quality of Life, Depression and Anxiety in Thyroid Cancer Patients , 2006, Quality of Life Research.
[47] F. Minuto,et al. A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma , 2005, Journal of endocrinological investigation.
[48] S. Bae,et al. Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases , 2005, Quality of Life Research.
[49] L. Chien,et al. Postoperative quality of life among patients with thyroid cancer. , 2004, Journal of advanced nursing.
[50] M. Wolzt,et al. Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy , 2003, Supportive Care in Cancer.
[51] P. Schultz,et al. Health profiles and quality of life of 518 survivors of thyroid cancer , 2003, Head & neck.
[52] Shinichiro,et al. Carcinoma , 1906, The Hospital.